NO903510L - Nye 2-oxo-1-oxa-8-azaspiro(4,5)decanderivater, farmasoeytiske preparater som inneholder dem og fremgangsmaate for fremstilling av dem. - Google Patents
Nye 2-oxo-1-oxa-8-azaspiro(4,5)decanderivater, farmasoeytiske preparater som inneholder dem og fremgangsmaate for fremstilling av dem.Info
- Publication number
- NO903510L NO903510L NO90903510A NO903510A NO903510L NO 903510 L NO903510 L NO 903510L NO 90903510 A NO90903510 A NO 90903510A NO 903510 A NO903510 A NO 903510A NO 903510 L NO903510 L NO 903510L
- Authority
- NO
- Norway
- Prior art keywords
- ylcarbonyl
- azaspiro
- oxa
- oxo
- alkyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- -1 piperidin-1-ylcarbonyl Chemical group 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- SEUNTAIZLCAWDW-UHFFFAOYSA-N 1-oxa-8-azaspiro[4.5]decan-2-one Chemical class O1C(=O)CCC11CCNCC1 SEUNTAIZLCAWDW-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000005115 alkyl carbamoyl group Chemical group 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000002082 anti-convulsion Effects 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001037 epileptic effect Effects 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 abstract 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 abstract 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 abstract 1
- 125000004953 trihalomethyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU894092A HU204054B (en) | 1989-08-10 | 1989-08-10 | Process for producing new 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives and pharmaceutical compositions comprising same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO903510D0 NO903510D0 (no) | 1990-08-09 |
| NO903510L true NO903510L (no) | 1991-02-11 |
Family
ID=10966859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO90903510A NO903510L (no) | 1989-08-10 | 1990-08-09 | Nye 2-oxo-1-oxa-8-azaspiro(4,5)decanderivater, farmasoeytiske preparater som inneholder dem og fremgangsmaate for fremstilling av dem. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5157038A (no) |
| EP (1) | EP0412820B1 (no) |
| JP (1) | JPH0377886A (no) |
| KR (1) | KR940002828B1 (no) |
| CN (2) | CN1028531C (no) |
| AT (1) | ATE102204T1 (no) |
| AU (1) | AU621239B2 (no) |
| DD (1) | DD299430A5 (no) |
| DE (1) | DE69006973T2 (no) |
| DK (1) | DK0412820T3 (no) |
| ES (1) | ES2062386T3 (no) |
| FI (1) | FI903973A7 (no) |
| HU (1) | HU204054B (no) |
| IE (1) | IE62297B1 (no) |
| IL (1) | IL95322A (no) |
| IS (1) | IS1578B (no) |
| MY (1) | MY107125A (no) |
| NO (1) | NO903510L (no) |
| NZ (1) | NZ234844A (no) |
| PL (2) | PL164653B1 (no) |
| YU (1) | YU47749B (no) |
| ZA (1) | ZA906298B (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756743A (en) * | 1996-04-10 | 1998-05-26 | Hoechst Marion Roussel Inc. | Spiro cyclopent b!indole-piperidines! |
| RU2006132465A (ru) * | 2004-02-10 | 2008-03-20 | Ф.Хоффманн-Ля Рош Аг (Ch) | Модуляторы хемокинового рецептора ccr5 |
| WO2008092887A1 (en) * | 2007-02-01 | 2008-08-07 | Glaxo Group Limited | I-oxa-3-azaspiro (4.5) decan-2-one and 1-oxa-3, 8-diazaspiro (4.5) decan-2-one derivatives for the treatment of eating disorders |
| PE20081735A1 (es) * | 2007-02-01 | 2009-01-18 | Glaxo Group Ltd | Derivados de 1-oxa-3[4,5]decan-2-ona en el tratamiento de trastornos alimenticios |
| JP6503008B2 (ja) * | 2017-05-30 | 2019-04-17 | 高級アルコール工業株式会社 | 透明油性固形化粧料 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL127065C (no) * | 1964-04-22 | |||
| US3594306A (en) * | 1967-04-03 | 1971-07-20 | Great Canadian Oil Sands | Separation cell and scavenger cell froths treatment |
| FR96352E (fr) * | 1967-12-29 | 1972-06-16 | Science Union & Cie | Nouveaux dérives du spiro (4,5) decane et leur procédé de préparation. |
| FR2036557A5 (no) * | 1969-03-25 | 1970-12-24 | Logeais Laboratoires | |
| GB1301254A (no) * | 1971-07-08 | 1972-12-29 | ||
| US3856797A (en) * | 1972-12-29 | 1974-12-24 | Yoshitomi Pharmaceutical | 8-aminoalkyl-3-oxo-1-thia-4,8-diazaspiro(4.5)decanes and analogs thereof |
| US4244961A (en) * | 1978-10-26 | 1981-01-13 | Syntex (U.S.A.) Inc. | 1-Oxa-3,8-diazaspiro[4.5]decan-2-ones antihypertensive agents |
| FR2615515B1 (fr) * | 1987-05-22 | 1989-06-30 | Adir | Nouveaux derives du spiro 4, 5 decane, leur procede de preparation et les compositions pharmaceutiques les renfermant |
| HU204529B (en) * | 1989-08-10 | 1992-01-28 | Richter Gedeon Vegyeszet | Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them |
-
1989
- 1989-08-10 HU HU894092A patent/HU204054B/hu not_active IP Right Cessation
-
1990
- 1990-08-08 KR KR1019900012167A patent/KR940002828B1/ko not_active Expired - Fee Related
- 1990-08-09 ZA ZA906298A patent/ZA906298B/xx unknown
- 1990-08-09 IL IL9532290A patent/IL95322A/en not_active IP Right Cessation
- 1990-08-09 NZ NZ234844A patent/NZ234844A/en unknown
- 1990-08-09 ES ES90308778T patent/ES2062386T3/es not_active Expired - Lifetime
- 1990-08-09 MY MYPI90001339A patent/MY107125A/en unknown
- 1990-08-09 JP JP2209360A patent/JPH0377886A/ja active Pending
- 1990-08-09 IE IE288390A patent/IE62297B1/en not_active IP Right Cessation
- 1990-08-09 EP EP90308778A patent/EP0412820B1/en not_active Expired - Lifetime
- 1990-08-09 DE DE69006973T patent/DE69006973T2/de not_active Expired - Fee Related
- 1990-08-09 AT AT90308778T patent/ATE102204T1/de not_active IP Right Cessation
- 1990-08-09 DD DD90343362A patent/DD299430A5/de not_active IP Right Cessation
- 1990-08-09 AU AU60805/90A patent/AU621239B2/en not_active Ceased
- 1990-08-09 DK DK90308778.1T patent/DK0412820T3/da active
- 1990-08-09 IS IS3613A patent/IS1578B/is unknown
- 1990-08-09 YU YU153990A patent/YU47749B/sh unknown
- 1990-08-09 NO NO90903510A patent/NO903510L/no unknown
- 1990-08-10 PL PL90286441A patent/PL164653B1/pl unknown
- 1990-08-10 CN CN90106920A patent/CN1028531C/zh not_active Expired - Fee Related
- 1990-08-10 US US07/566,274 patent/US5157038A/en not_active Expired - Fee Related
- 1990-08-10 CN CN90106982A patent/CN1029403C/zh not_active Expired - Fee Related
- 1990-08-10 FI FI903973A patent/FI903973A7/fi not_active Application Discontinuation
- 1990-08-10 PL PL90300608A patent/PL164654B1/pl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY107240A (en) | Novel 2-oxo-3, 8-diazaspiro [4,5] decane derivatives, pharmaceuticals compositions containing them and process for preparing same. | |
| SI1216245T1 (en) | Pharmaceutically active sulfonyl hydrazide derivatives | |
| DK0414422T3 (da) | 2-Oxo-1-oxa-8-azaspiro(4,5)decan-derivater, fremgangsmåder til deres fremstilling samt præparater deraf | |
| NO903510L (no) | Nye 2-oxo-1-oxa-8-azaspiro(4,5)decanderivater, farmasoeytiske preparater som inneholder dem og fremgangsmaate for fremstilling av dem. | |
| NO903512L (no) | Nye 1-oxa-2-oxo-8-azaspiro(4,5)decanderivater, farmasoeytiske preparater som inneholder dem og fremgangsmaate for fremstilling av dem. | |
| NO164098C (no) | Analogifremgangsmaate for fremstilling av nye racemisk eller optisk aktive, terapeutisk aktive berbanderivater. | |
| DE3781044D1 (de) | Prophylaktische und heilende zusammensetzung enthaltende eine 8-chlorbenzothiazepin-verbindung und dessen verwendung. | |
| HU9302081D0 (en) | Procedure for producing preparations for preventing and/or curing ulceral diseases |